311 related articles for article (PubMed ID: 7019742)
1. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
[TBL] [Abstract][Full Text] [Related]
2. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
Malkovský M; Bubeník J; Holán V; Hasek M
Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
Hayashi S
Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
[TBL] [Abstract][Full Text] [Related]
4. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
5. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
Kharkevich DD; Suslov AP
Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
[No Abstract] [Full Text] [Related]
6. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
7. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
8. Immune reactivity of spleen cells in advanced stages of tumor growth.
Oisgold-Dagá S; Jasnis MA; Klein S; de Bonaparte YP
Biomed Pharmacother; 1982; 36(6-7):319-23. PubMed ID: 6763881
[TBL] [Abstract][Full Text] [Related]
9. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ].
Schäffner H
Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671
[TBL] [Abstract][Full Text] [Related]
10. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
11. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
12. [Study of immunosuppressive effect of measles virus. In vitro effect of the leukocyte migration inhibition test (author's transl)].
Sakiyama Y
Hokkaido Igaku Zasshi; 1980 Jul; 55(4):315-22. PubMed ID: 7009364
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
Nĕmecková S; Bubeník J; Indrová M
Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
[TBL] [Abstract][Full Text] [Related]
16. [The role of tumor hybrid cells in antitumor immunity. II. Comparison of antigenicity of tumor hybrid cells and ascitic hepatoma cells by leukocyte migration inhibition test].
Tong YX
Zhonghua Zhong Liu Za Zhi; 1983 Jul; 5(4):259-61. PubMed ID: 6653340
[No Abstract] [Full Text] [Related]
17. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
[TBL] [Abstract][Full Text] [Related]
18. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
Rocklin RE
J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
[No Abstract] [Full Text] [Related]
19. Applications of the macrophage electrophoretic mobility test (M.E.M.).
Shenton BR
Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
Geczy CL; Meyer PA
J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
